Onopordopicrin from the new genus Shangwua as a novel thioredoxin reductase inhibitor to induce oxidative stress-mediated tumor cell apoptosis.
Junmin ZhangZai-Qin ZhengQianhe XuYa LiKun GaoJian-Guo FangPublished in: Journal of enzyme inhibition and medicinal chemistry (2021)
Isolation and identification of natural products from plants is an essential approach for discovering drug candidates. Herein we report the characterization of three sesquiterpene lactones from a new genus Shangwua, e.g. onopordopicrin (ONP), C2, and C3, and evaluation of their pharmacological functions in interfering cellular redox signaling. Compared to C2 and C3, ONP shows the most potency in killing cancer cells. Further experiments demonstrate that ONP robustly inhibits thioredoxin reductase (TrxR), which leads to perturbation of cellular redox homeostasis with the favor of oxidative stress. Knockdown of the TrxR sensitizes cells to the ONP treatment while overexpression of the enzyme reduces the potency of ONP, underpinning the correlation of TrxR inhibition to the cytotoxicity of ONP. The discovery of ONP expands the library of the natural TrxR inhibitors, and the disclosure of the action mechanism of ONP provides a foundation for the further development of ONP as an anticancer agent.
Keyphrases
- induced apoptosis
- oxidative stress
- endoplasmic reticulum stress
- cell proliferation
- signaling pathway
- dna damage
- ischemia reperfusion injury
- diabetic rats
- small molecule
- emergency department
- cell cycle arrest
- high throughput
- transcription factor
- combination therapy
- electron transfer
- heat shock
- single cell
- replacement therapy
- electronic health record
- adverse drug
- bioinformatics analysis
- heat stress